New Alzheimer's drug shows early promise - WMC Action News 5 - Memphis, Tennessee

New Alzheimer's drug shows early promise

(Source: NBC News) (Source: NBC News)
NEW YORK, NY (NBC) -

An experimental drug for Alzheimer's disease is showing early promise. 

Drug maker Biogen developed the drug, called "Aducanumab."   

Biogen funded the latest research. 

The drug was found to greatly reduce plaques in the brain, which experts believe play a critical role in the development of the disease.

Experts are cautious, and say the study was too small to prove any real clinical benefit just yet.

Previous drugs have been positive and encouraging in early trials, but later failed.

Some say this new research is still promising.
 
"These plaques can start to surface years, even like a decade before symptoms start," Dr. Natalie Azar of NYU Langone Medical Center said. "So, imagine if you could take a population of people who are at risk, either by screening or genetic risk, and give them this drug that early and prevent the plaques from ever developing. Could that then translate into a truly meaningful treatment for Alzheimer's?"

Researchers hope to know more when all of the research is finished. They say it should be completed by 2020.

Copyright 2016 NBC News. All rights reserved.

Powered by Frankly